TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 117 filers reported holding TARSUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $18,223 | +132.1% | 670,459 | +210.5% | 0.12% | +106.7% |
| Q1 2024 | $7,850 | +66.5% | 215,958 | -7.3% | 0.06% | +93.5% |
| Q4 2023 | $4,716 | -33.4% | 232,900 | -41.6% | 0.03% | -54.4% |
| Q3 2023 | $7,084 | +101.2% | 398,641 | +104.6% | 0.07% | +134.5% |
| Q2 2023 | $3,520 | – | 194,821 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,089,856 | $35,778,000 | 4.39% |
| Vivo Capital, LLC | 2,262,200 | $38,729,000 | 4.28% |
| Cormorant Asset Management, LP | 1,971,422 | $33,751,000 | 2.36% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $30,602,000 | 2.36% |
| Sands Capital Ventures, LLC | 260,000 | $4,451,000 | 1.29% |
| COWEN AND COMPANY, LLC | 522,329 | $8,942,000 | 0.86% |
| RTW INVESTMENTS, LP | 2,023,179 | $34,637,000 | 0.80% |
| Perceptive Advisors | 1,296,416 | $22,194,000 | 0.64% |
| Ghost Tree Capital, LLC | 120,000 | $2,054,000 | 0.58% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $22,671,000 | 0.45% |